Comprehensive search ChatGPT Online Scientific research tools Facebook Group Tools Telegram
Sign in Sign Up

Science Hub 每 Free Research Papers | Academic Community


[Elsevier] Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial

jlmarti0512 Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-01 08:17
Reward10points

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trialChristopher J Sweeney 1, Andrew J Martin 2, Martin R Stockler 3, Stephen Begbie 4, Leanna Cheung 2, Kim N Chi 5, Simon Chowdhury 6, Mark Frydenberg 7, Lisa G Horvath 8, Anthony M Joshua 9, Nicola J Lawrence 10, Gavin Marx 11, John McCaffrey 12, Ray McDermott 13, Margaret McJannett 14, Scott A North 15, Francis Parnis 16, Wendy Parulekar 17, David W Pook 18, Martin Neil Reaume 19, Shahneen K Sandhu 20, Alvin Tan 21, Thean Hsiang Tan 22, Alastair Thomson 23, Francisco Vera-Badillo 24, Scott G Williams 20, Diana Winter 2, Sonia Yip 2, Alison Y Zhang 25, Robert R Zielinski 26, Ian D Davis 27; ENZAMET trial investigators and Australian and New Zealand Urogenital and Prostate Cancer Trials Group


Collaborators, Affiliations expand

You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

Advanced Mode
B Color Image Link Quote Code Smilies
You have to log in before you can reply Login | Register

Points Rules

jlmarti0512 Lv.4
Senior Member

  • post

  • reply

  • points

    810

Same Category


Latest Reply

Announcement

Daily Top Contributors

Return to the list